FT ACID REDUCER 20 MG TABLET
FDA nonproprietary name: famotidine
For 30 tablets
Pharmacies pay
$4.15 filed
30 × $0.13819 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$9.77 estimated
$4.15 + $0.62 (15%) + $5.00 fee per fill = $9.77
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
FT ACID REDUCER 20 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as famotidine, under the trade name “foster and thrive acid reducer”.
FDA gives its dosage form as tablet, film coated and its route as oral.
The labeler, the company named on the label, is Strategic Sourcing Services LLC.
FDA’s Established Pharmacologic Class for it is Histamine-2 Receptor Antagonist.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and marks it as sold over the counter.
What pharmacies pay
Pharmacies pay $4.15 for 30 tablets (30 × $0.13819 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
All 2 NDCs
- 70677-1101-01 · Strategic Sourcing Services LLC · $0.13819 per EA · eff. 2026-09-23 filed
- 70677-1101-02 · Strategic Sourcing Services LLC · $0.13819 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
14 other products in the NADAC file share the FDA nonproprietary name famotidine with FT ACID REDUCER 20 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ACID REDUCER 20 MG TABLET | $0.13819 per EA filed | We don’t know yet |
| FAMOTIDINE 10 MG TABLET | $0.0947 per EA filed | We don’t know yet |
| FAMOTIDINE 20 MG TABLET | $0.02886 to $0.13819 per EA filed | We don’t know yet |
| FAMOTIDINE 20 MG/2 ML VIAL | $0.30272 per ML filed | $0.36 per ML derived |
| FAMOTIDINE 40 MG TABLET | $0.04834 per EA filed | We don’t know yet |
| FAMOTIDINE 40 MG/5 ML SUSP | $0.07341 to $0.4942 per ML filed | We don’t know yet |
| FT ACID REDUCER 10 MG TABLET | $0.0947 per EA filed | We don’t know yet |
| FT ACID REDUCER 20 MG TABLET this page | $0.13819 per EA filed | We don’t know yet |
| GNP ACID REDUCER 10 MG TABLET | $0.0947 per EA filed | We don’t know yet |
| GNP ACID REDUCER 20 MG TABLET | $0.13819 per EA filed | We don’t know yet |
| GS ACID REDUCER 10 MG TABLET | $0.0947 per EA filed | We don’t know yet |
| GS ACID REDUCER 20 MG TABLET | $0.13819 per EA filed | We don’t know yet |
| HEARTBURN RELIEF 10 MG TABLET | $0.0947 per EA filed | We don’t know yet |
| HEARTBURN RELIEF 20 MG TABLET | $0.13819 per EA filed | We don’t know yet |
| QC FAMOTIDINE 20 MG TABLET | $0.13819 per EA filed | We don’t know yet |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $0.13819 per EA filed.
Of the 23 other products in FDA’s Histamine-2 Receptor Antagonist class priced per EA, 11 have a higher middle NADAC price and 7 a lower one; 5 have the same. The one in the middle is QC FAMOTIDINE 20 MG TABLET, at $0.13819 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- It is sold over the counter, so shelf prices vary from store to store: what does it cost per unit here?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- CIMETIDINE 200 MG TABLET
- IBUPROFEN-FAMOTIDIN 800-26.6 MG
- NIZATIDINE 150 MG CAPSULE
- ACID REDUCER COMPLETE TAB CHEW
- CIMETIDINE 300 MG/5 ML SOLN